Baidu
map

Circulation:不同去肾神经方法治疗顽固性高血压

2018-09-26 荷塘月影 医学论坛网心血管

难治性高血压是指联合服用3种或以上合适剂量的抗高血压药物(其中一种为利尿剂),仍然无法控制的高血压。

难治性高血压是指联合服用3种或以上合适剂量的抗高血压药物(其中一种为利尿剂),仍然无法控制的高血压。肾交感神经活动是血压维持和升高的重要环节,肾交感神经的激活对高血压的发生及发展具有重要作用,其主要机制为影响肾脏血管收缩、增加肾素释放和加强水钠重吸收。肾交感神经射频消融术对难治性高血压患者具有肯定的降压效果。德国莱比锡大学心脏中心的Karl Fengler等人进行了一项头对头的比较研究(RADIOSOUND-HTN研究),观察不同的去肾神经技术对于顽固性高血压的疗效。研究者将顽固性高血压患者以1:1:1的比例随机分到:1)肾主动脉射频消融RDN,2)肾主动脉、侧支和附件的射频消融RDN,或3)基于血管内超声能源的RDN。主要终点是3个月白天动态收缩压(ABPM)的变化。该研究在2015年6月至2018年6月,共招募了120名患者(平均年龄64±9岁,白天平均血压153/86±12/13mmHg)。其中39例随机分到肾主动脉射频消融术,39例随机分到肾主动和侧支射频消融,42例随机分到超声RDN。各组之间的基线日间血压、临床特征和治疗方法均衡。在3个月时,整个队列患者的白天动态收缩压下降

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=923440, encodeId=72729234404f, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22945459306, createdName=ms4000000125336763, createdTime=Sun Feb 07 11:06:26 CST 2021, time=2021-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632882, encodeId=3eec1632882aa, content=<a href='/topic/show?id=5e1110013180' target=_blank style='color:#2F92EE;'>#顽固性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100131, encryptionId=5e1110013180, topicName=顽固性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e4121955726, createdName=limedical1981, createdTime=Sat May 18 08:26:00 CST 2019, time=2019-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346846, encodeId=7d3e346846aa, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Thu Sep 27 00:15:58 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346831, encodeId=e567346831c0, content=不错的文章值得拥有哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Wed Sep 26 22:22:17 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346822, encodeId=1bfd34682246, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Wed Sep 26 21:12:38 CST 2018, time=2018-09-26, status=1, ipAttribution=)]
    2021-02-07 ms4000000125336763

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=923440, encodeId=72729234404f, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22945459306, createdName=ms4000000125336763, createdTime=Sun Feb 07 11:06:26 CST 2021, time=2021-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632882, encodeId=3eec1632882aa, content=<a href='/topic/show?id=5e1110013180' target=_blank style='color:#2F92EE;'>#顽固性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100131, encryptionId=5e1110013180, topicName=顽固性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e4121955726, createdName=limedical1981, createdTime=Sat May 18 08:26:00 CST 2019, time=2019-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346846, encodeId=7d3e346846aa, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Thu Sep 27 00:15:58 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346831, encodeId=e567346831c0, content=不错的文章值得拥有哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Wed Sep 26 22:22:17 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346822, encodeId=1bfd34682246, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Wed Sep 26 21:12:38 CST 2018, time=2018-09-26, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=923440, encodeId=72729234404f, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22945459306, createdName=ms4000000125336763, createdTime=Sun Feb 07 11:06:26 CST 2021, time=2021-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632882, encodeId=3eec1632882aa, content=<a href='/topic/show?id=5e1110013180' target=_blank style='color:#2F92EE;'>#顽固性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100131, encryptionId=5e1110013180, topicName=顽固性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e4121955726, createdName=limedical1981, createdTime=Sat May 18 08:26:00 CST 2019, time=2019-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346846, encodeId=7d3e346846aa, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Thu Sep 27 00:15:58 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346831, encodeId=e567346831c0, content=不错的文章值得拥有哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Wed Sep 26 22:22:17 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346822, encodeId=1bfd34682246, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Wed Sep 26 21:12:38 CST 2018, time=2018-09-26, status=1, ipAttribution=)]
    2018-09-27 smartxiuxiu

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=923440, encodeId=72729234404f, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22945459306, createdName=ms4000000125336763, createdTime=Sun Feb 07 11:06:26 CST 2021, time=2021-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632882, encodeId=3eec1632882aa, content=<a href='/topic/show?id=5e1110013180' target=_blank style='color:#2F92EE;'>#顽固性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100131, encryptionId=5e1110013180, topicName=顽固性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e4121955726, createdName=limedical1981, createdTime=Sat May 18 08:26:00 CST 2019, time=2019-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346846, encodeId=7d3e346846aa, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Thu Sep 27 00:15:58 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346831, encodeId=e567346831c0, content=不错的文章值得拥有哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Wed Sep 26 22:22:17 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346822, encodeId=1bfd34682246, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Wed Sep 26 21:12:38 CST 2018, time=2018-09-26, status=1, ipAttribution=)]
    2018-09-26 1e1b8538m79(暂无匿称)

    不错的文章值得拥有哦

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=923440, encodeId=72729234404f, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22945459306, createdName=ms4000000125336763, createdTime=Sun Feb 07 11:06:26 CST 2021, time=2021-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632882, encodeId=3eec1632882aa, content=<a href='/topic/show?id=5e1110013180' target=_blank style='color:#2F92EE;'>#顽固性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100131, encryptionId=5e1110013180, topicName=顽固性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e4121955726, createdName=limedical1981, createdTime=Sat May 18 08:26:00 CST 2019, time=2019-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346846, encodeId=7d3e346846aa, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Thu Sep 27 00:15:58 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346831, encodeId=e567346831c0, content=不错的文章值得拥有哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Wed Sep 26 22:22:17 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346822, encodeId=1bfd34682246, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Wed Sep 26 21:12:38 CST 2018, time=2018-09-26, status=1, ipAttribution=)]
    2018-09-26 医者仁心5538

    学习了

    0

相关资讯

CIT 2014:SYMPLICITY HTN-3后时代,去肾神经治疗顽固性高血压路在何方?

顽固性高血压是一种特殊类型的高血压,在应用包括利尿剂在内的3种或以上的足量降压药血压仍难以达标或至少需4种降压药血压才能达标,可能导致严重的靶器官损伤和心血管风险,治疗十分棘手[1]。近年来国外已有前瞻性队列研究和随机对照研究表明[2-4],经导管射频消融肾交感神经术(renal sympathetic denervation,RDN)对于部分顽固性高血压患者具有显著持久的降压作用,且很少发生

Baidu
map
Baidu
map
Baidu
map